What question did this study set out to answer?

The aim is to evaluate the protective effects of taurochenodeoxycholic acid (TCDCA) on corneal endothelial cells in Fuchs' endothelial corneal dystrophy (FECD).

February 8, 2026Investigative Ophthalmology & Visual Science0 citationsOpen Access

View Full Paper

Taurochenodeoxycholic Acid Activates Calcium Signaling to Protect Against Fuchs’ Endothelial Corneal Dystrophy

YQYujie QiaoShandong Eye Hospital CZCan ZhaoShandong Eye Hospital SYS. C. YaoShandong Eye Hospital

Key Points

The aim is to evaluate the protective effects of taurochenodeoxycholic acid (TCDCA) on corneal endothelial cells in Fuchs' endothelial corneal dystrophy (FECD).
In vitro experiments on corneal endothelial cells
Exposure to TCDCA
Assessment of calcium signaling pathways
TCDCA effectively protects corneal endothelial cells from damage
Activation of calcium signaling was observed
TCDCA may slow the progression of FECD

Abstract

TCDCA demonstrated a protective effect on corneal endothelial cells during the pathogenesis of FECD. Therefore, TCDCA may be a promising novel therapeutic target for attenuating the progression of FECD.

问 AI

Bookmark

View Full Paper

问 AI

Bookmark

View Full Paper

Taurochenodeoxycholic Acid Activates Calcium Signaling to Protect Against Fuchs’ Endothelial Corneal Dystrophy

Key Points

Abstract

Cite This Study

Also Consider

Also Consider